R. Boyer

Comparison of Neutralizing Antibody Assays for Receptor Binding and Enzyme Activity of the Enzyme Replacement Therapeutic Naglazyme® (Galsulfase)

Joleen T White, E. Foehr, Lisa Argento Martell, 2008, The AAPS Journal.

Development, Validation, and Clinical Implementation of an Assay to Measure Total Antibody Response to Naglazyme® (Galsulfase)

G. Taniguchi, E. Foehr, Ryan Boyer, 2008, The AAPS Journal.

Achieving efficacy in subjects with sustained pegvaliase-neutralizing antibody responses.

K. Larimore, S. Zoog, J. Olbertz, 2021, Molecular genetics and metabolism.

Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials

B. Schweighardt, K. Larimore, J. Atkinson, 2018, EBioMedicine.

Knockdown of Crispld2 in zebrafish identifies a novel network for nonsyndromic cleft lip with or without cleft palate candidate genes

J. Mulliken, S. Blanton, J. Hecht, 2018, European Journal of Human Genetics.

Knockdown of Crispld2 in zebrafish identifies a novel network for nonsyndromic cleft lip with or without cleft palate candidate genes

J. Mulliken, S. Blanton, J. Hecht, 2018, European Journal of Human Genetics.